AbbVie-backed ADARx plans IPO to fund array of siRNA med trials
AbbVie-backed ADARx Pharmaceuticals plans an IPO to fund its clinical-stage siRNA therapy pipeline.
ADARx Pharmaceuticals
Private
ADARx Pharmaceuticals is a clinical-stage biotechnology company developing RNA-based therapeutics using its proprietary ADAR (Adenosine Deaminase Acting on RNA) editing platform. The company is allied with AbbVie and has three drugs in the clinic.
Company Info
Sector:RNA Therapeutics
Headquarters:San Diego, California, United States
Founded:2019
Website:www.adarx.com/